Single Photon Emission Computed Tomography/Computed Tomography Imaging in Thyroid Cancer
PDF
Cite
Share
Request
Review
P: 21-30
April 2016

Single Photon Emission Computed Tomography/Computed Tomography Imaging in Thyroid Cancer

Nucl Med Semin 2016;2(1):21-30
1. Milli Onkoloji Merkezi Nükleer Tip Bölümü, Radyonüklid Tedavi Ünitesi, Bakü, Azerbaycan
2. Istanbul Üniversitesi Cerrahpasa Tip Fakültesi, Nükleer Tip Anabilim Dali, Istanbul, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

In this study, we aimed to evaluate the value of single photon emission computed tomography/computed tomography (SPECT/CT) in patients with differentiated thyroid cancer. Although the utility of radioiodine SPECT/CT imaging is controversial in the clinical management of thyroid cancer patients, SPECT/CT is a valuable method in the staging, risk stratification and follow-up of thyroid cancer. Also, in deciding therapy approach, SPECT/CT seems to be an important modality by helping correct localization of activity foci seen on planar radioiodine scintgraphy. Additionally, it had a further clinical impact on the patient management by influencing referral I-131 treatment and tailoring of the administered radioidodine dose, and/or the addition of surgery or external radiation therapy in the cases of non-avid recurrence-metastatic disease.